Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Panacea Biotec Pharma Limited, is an unlisted public company incorporated on 22 March, 2019. It is classified as a public limited company and is located in South Delhi, Delhi. It's authorized share capital is INR 60.00 cr and the total paid-up capital is INR 10.00 lac.
Panacea Biotec Pharma Limited's operating revenue range is INR 100 cr - 500 cr for the financial year ending on 31 March, 2023. It's EBITDA has decreased by 217.12% over the previous year. At the same time, it's book networth has increased by 12.6%.
Read more
** All rupee values in INR crores. Based on March 2024 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
State | Type | Address |
---|
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Managing Director | Rajesh Jain
Shareholder
|
00013053 | 6 years |
Whole-time Director | Narotam Kumar Juneja | 01204817 | 3 years |
Director | Ankesh Jain
Shareholder
|
03556647 | 6 years |
Director | Manjula Upadhyay | 07137968 | 4 years |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Networth | |||||
Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2024 available in Tofler Pro
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
As per information available, the company has no registered charges.
Name | Status | Paid up Capital | Common Directors | Address |
---|---|---|---|---|
PANERA BIOTEC PRIVATE LIMITED |
Active
|
84.0 L | 1 | Delhi |
ADVETA POWER PRIVATE LIMITED |
Active
|
18.0 L | 2 | Himachal Pradesh |
PANACEA BIOTEC LIMITED |
Active
|
22.3 Cr | 4 | Punjab |
MR LEX CORP LLP |
Active
|
2.0 L | 1 | Delhi |
THE DELHI FLOUR MILLS COMPANY LIMITED |
Active
|
1.8 Cr | 1 | Delhi |
Read more
The incorporation date of PANACEA BIOTEC PHARMA LIMITED is 22 March, 2019
The authorized share capital of PANACEA BIOTEC PHARMA LIMITED is INR ₹ 60.0 Cr.
The paid-up capital of PANACEA BIOTEC PHARMA LIMITED is INR ₹ 10.0 L.
The registered address of PANACEA BIOTEC PHARMA LIMITED is B-1 Extension/A-27, Mohan Co-operative Industrial Estate, Mathura Road NEW DELHI South Delhi Delhi - 110044
The CIN number of PANACEA BIOTEC PHARMA LIMITED is U24299DL2019PLC347566.